What is the appropriate blood pressure control strategy for a 37-year-old African American male currently taking lisinopril 10 mg daily and amlodipine 10 mg daily?

Blood Pressure Management Strategy

Add a thiazide or thiazide-like diuretic to the current regimen of lisinopril 10mg and amlodipine 10mg. This patient is already on dual therapy with an ACE inhibitor and calcium channel blocker at maximum doses, and according to the 2020 ISH guidelines for Black patients, the next step is adding a diuretic 1.

Current Medication Assessment

This 37-year-old African American male is currently on:

• Lisinopril 10mg (ACE inhibitor at standard dose)
• Amlodipine 10mg (DHP-CCB at maximum dose)

Both medications are at or near their maximum recommended doses for hypertension 2, 3.

Race-Specific Treatment Algorithm

The 2020 ISH guidelines provide a clear stepwise approach specifically for Black patients 1:

Step 1: Low-dose ARB + DHP-CCB OR DHP-CCB + thiazide/thiazide-like diuretic
Step 2: Increase to full dose
Step 3: Add diuretic OR ARB/ACEI ← This patient is here
Step 4: Add spironolactone (or alternatives: amiloride, doxazosin, eplerenone, clonidine, or beta-blocker if spironolactone not tolerated/contraindicated)

Recommended Action

Add a thiazide-like diuretic (such as chlorthalidone 12.5-25mg daily or hydrochlorothiazide 12.5-25mg daily) to the existing regimen. This represents the guideline-concordant third step for Black patients with uncontrolled hypertension 1.

Supporting Evidence:

• Research demonstrates that when ACE inhibitor/CCB combinations fail to control BP, a diuretic is more effective than a beta-blocker as the third agent 4
• The combination of ACE inhibitor + CCB + diuretic has proven efficacy in achieving BP control across multiple studies 5, 6
• Black patients specifically benefit from diuretic-based regimens, as demonstrated in ALLHAT where chlorthalidone showed superior outcomes 7

Blood Pressure Targets

Target BP: <130/80 mmHg 1. This is the standard target for non-elderly, non-frail patients per ISH 2020 guidelines. The goal should be achieved within 3 months of treatment adjustment 1.

Monitoring Plan

• Recheck BP in 2-4 weeks after adding the diuretic
• Monitor for:
  • Electrolyte abnormalities (hypokalemia, hyponatremia) - check basic metabolic panel in 2-4 weeks
  • Renal function (creatinine) - particularly important given ACE inhibitor use 3
  • Orthostatic hypotension - measure BP supine and standing
  • Adherence - confirm patient is taking medications as prescribed 1

Important Caveats

If BP remains uncontrolled after adding diuretic:

Consider spironolactone 25-50mg daily as the fourth agent 1. Spironolactone is particularly effective in resistant hypertension and is the preferred fourth-line agent per guidelines.

Alternative considerations if diuretic contraindicated:

• Could switch from lisinopril to an ARB (though less evidence for superiority in this scenario)
• However, ACE inhibitors have demonstrated superiority over ARBs for preventing myocardial infarction and total mortality 8, so maintaining lisinopril is preferable

Lifestyle modifications:

Should be reinforced at every visit when BP ≥115/75 mmHg 9, including:

• Sodium restriction (<2g/day)
• Weight loss if overweight
• Regular aerobic exercise
• Alcohol moderation
• DASH diet pattern

Common Pitfalls to Avoid

1. Don't switch to monotherapy or reduce doses - this patient needs intensification, not simplification
2. Don't add a beta-blocker as third agent - evidence shows diuretics are superior in this scenario 4
3. Don't delay treatment escalation - target BP should be achieved within 3 months 1
4. Don't forget to assess adherence - non-adherence is a common cause of apparent treatment resistance
5. Don't overlook secondary hypertension - in a young patient with resistant hypertension, consider screening for secondary causes (renal artery stenosis, primary aldosteronism, sleep apnea)